BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 17085183)

  • 1. The cost-effectiveness of dextranomer/hyaluronic acid copolymer for the management of vesicoureteral reflux. 2. Reflux correction at the time of diagnosis as a substitute for traditional management.
    Benoit RM; Peele PB; Cannon GM; Docimo SG
    J Urol; 2006 Dec; 176(6 Pt 1):2649-53; discussion 2653. PubMed ID: 17085183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cost-effectiveness of dextranomer/hyaluronic acid copolymer for the management of vesicoureteral reflux. 1: substitution for surgical management.
    Benoit RM; Peele PB; Docimo SG
    J Urol; 2006 Oct; 176(4 Pt 1):1588-92; discussion 1592. PubMed ID: 16952694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cost-effectiveness of endoscopic injection of dextranomer/hyaluronic acid copolymer for vesicoureteral reflux.
    Kobelt G; Canning DA; Hensle TW; Läckgren G
    J Urol; 2003 Apr; 169(4):1480-4; discdussion 1484-5. PubMed ID: 12629396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endoscopic subureteral injection is not less expensive than outpatient open reimplantation for unilateral vesicoureteral reflux.
    Saperston K; Smith J; Putman S; Matern R; Foot L; Wallis C; deVries C; Snow B; Cartwright P
    J Urol; 2008 Oct; 180(4 Suppl):1626-9; discussion 1629-30. PubMed ID: 18715586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent trends in the surgical management of primary vesicoureteral reflux in the era of dextranomer/hyaluronic acid.
    Herbst KW; Corbett ST; Lendvay TS; Caldamone AA
    J Urol; 2014 May; 191(5 Suppl):1628-33. PubMed ID: 24679885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome analysis of mini-ureteroneocystostomy versus dextranomer/hyaluronic acid copolymer injection for unilateral vesicoureteral reflux.
    Ashley R; Vandersteen D
    J Urol; 2008 Oct; 180(4 Suppl):1611-3; discussion 1614. PubMed ID: 18710741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dextranomer/hyaluronic acid endoscopic injection is effective in the treatment of intermediate and high grade vesicoureteral reflux in patients with complete duplex systems.
    Hunziker M; Mohanan N; Puri P
    J Urol; 2013 May; 189(5):1876-81. PubMed ID: 23159268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Learning from the learning curve: factors associated with successful endoscopic correction of vesicoureteral reflux using dextranomer/hyaluronic acid copolymer.
    Dave S; Lorenzo AJ; Khoury AE; Braga LH; Skeldon SJ; Suoub M; Farhat W; Pippi Salle JL; Bägli DJ
    J Urol; 2008 Oct; 180(4 Suppl):1594-9; discussion 1599-600. PubMed ID: 18710756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoscopic treatment of moderate and high grade vesicoureteral reflux in infants using dextranomer/hyaluronic acid.
    Puri P; Mohanan N; Menezes M; Colhoun E
    J Urol; 2007 Oct; 178(4 Pt 2):1714-6; discussion 1717. PubMed ID: 17707016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single center experience with endoscopic subureteral dextranomer/hyaluronic acid injection as first line treatment in 1,551 children with intermediate and high grade vesicoureteral reflux.
    Puri P; Kutasy B; Colhoun E; Hunziker M
    J Urol; 2012 Oct; 188(4 Suppl):1485-9. PubMed ID: 22906657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endoscopic treatment with dextranomer-hyaluronic acid for vesicoureteral reflux: histological findings.
    Stenberg A; Larsson E; Läckgren G
    J Urol; 2003 Mar; 169(3):1109-13. PubMed ID: 12576864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subureteral injection of dextranomer/hyaluronic acid copolymer for persistent vesicoureteral reflux following ureteroneocystostomy.
    Jung C; DeMarco RT; Lowrance WT; Pope JC; Adams MC; Dietrich MS; Brock JW
    J Urol; 2007 Jan; 177(1):312-5. PubMed ID: 17162075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Febrile urinary tract infections after ureteroneocystostomy and subureteral injection of dextranomer/hyaluronic acid for vesicoureteral reflux--do choice of procedure and success matter?
    Dwyer ME; Husmann DA; Rathbun SR; Weight CJ; Kramer SA
    J Urol; 2013 Jan; 189(1):275-82. PubMed ID: 23174239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoscopic injection of dextranomer/hyaluronic acid copolymer to correct vesicoureteral reflux following failed ureteroneocystostomy.
    Kitchens D; Minevich E; DeFoor W; Reddy P; Wacksman J; Sheldon C; Koyle M
    J Urol; 2006 Oct; 176(4 Pt 2):1861-3. PubMed ID: 16945674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salvage dextranomer-hyaluronic acid copolymer for persistent reflux after ureteral reimplantation: early success rates.
    Bar-Yosef Y; Castellan M; Joshi D; Labbie A; Gosalbez R
    J Urol; 2011 Jun; 185(6 Suppl):2531-4. PubMed ID: 21555029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical Outcome Analysis of Pneumovesicoscopic Ureteral Reimplantation and Endoscopic Dextranomer/Hyaluronic Acid Injection for Primary Vesicoureteral Reflux in Children: A Multicenter 12-Year Review.
    Chung KLY; Sihoe J; Liu K; Chao N; Hung J; Liu C; Yam F; Leung Y; Tam P; Lee KH; Leung M
    J Laparoendosc Adv Surg Tech A; 2018 Mar; 28(3):348-353. PubMed ID: 29271690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoscopic Injection of Dextranomer/Hyaluronic Acid as First Line Treatment in 851 Consecutive Children with High Grade Vesicoureteral Reflux: Efficacy and Long-Term Results.
    Friedmacher F; Colhoun E; Puri P
    J Urol; 2018 Sep; 200(3):650-655. PubMed ID: 29551405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Subureteral Endoscopic Injection of Dextranomer/Hyaluronic Acid and Lich-Gregoir Ureteral Reimplantation in the Treatment of Pediatric Primary Vesicoureteral Reflux: A Prospective Randomized Study.
    Salih EM; Eldamanhory H; Selmy GI; Galal HA
    J Laparoendosc Adv Surg Tech A; 2021 Jun; 31(6):719-723. PubMed ID: 33751917
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of vesicoureteral reflux by endoscopic injection of dextranomer/hyaluronic Acid copolymer: preliminary results.
    Puri P; Chertin B; Velayudham M; Dass L; Colhoun E
    J Urol; 2003 Oct; 170(4 Pt 2):1541-4; discussion 1544. PubMed ID: 14501655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multivariate comparison of the efficacy of intraureteral versus subtrigonal techniques of dextranomer/hyaluronic acid injection.
    Routh JC; Reinberg Y; Ashley RA; Inman BA; Wolpert JJ; Vandersteen DR; Husmann DA; Kramer SA
    J Urol; 2007 Oct; 178(4 Pt 2):1702-5; discussion 1705-6. PubMed ID: 17707019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.